FMI
MURA

F/M Investments’s Mural Oncology MURA Stock Holding History

F/M Investments’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-77,567
Closed -$192K – 426
2025
Q2 		$192K Buy
+77,567
New +$183K 0.01% 398

Other funds holding MURA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

F/M Investments's MURA Position: Q3 2025 in Review

F/M Investments sold out of Mural Oncology (MURA) in Q3 2025, closing a stake of 77,567 shares — an estimated $192K sold.

F/M Investments first reported a position in MURA in Q2 2025 and held it in 1 quarter. The position peaked at $192K in Q2 2025. 61 funds tracked by Wall St. Rank hold MURA as of Q3 2025.

  • F/M Investments reported no remaining Mural Oncology position as of Q3 2025 after selling out during the quarter.
  • F/M Investments sold 77,567 Mural Oncology shares in Q3 2025, an estimated $192K.
  • F/M Investments first reported a position in Mural Oncology in Q2 2025 and held it in 1 quarter.
  • F/M Investments's Mural Oncology position peaked at $192K in Q2 2025.
  • 61 funds tracked by Wall St. Rank held Mural Oncology as of Q3 2025.

Based on F/M Investments's 13F filing for Q3 2025, filed 13 Nov 2025.